HMC
Harvard Management Company Portfolio holdings
AUM
$1.44B
This Quarter Return
-4.84%
1 Year Return
+33.17%
3 Year Return
+230.83%
5 Year Return
+163.57%
10 Year Return
+194.2%
AUM
$1.07B
AUM Growth
+$1.07B
(-38%)
Cap. Flow
-$550M
Cap. Flow
% of AUM
-51.67%
Top 10 Holdings %
Top 10 Hldgs %
75.23%
Holding
55
New
15
Increased
–
Reduced
5
Closed
9
Top Buys
| 1 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
$35.9M |
| 2 |
Grab
GRAB
|
$14.3M |
| 3 |
Confluent
CFLT
|
$9.94M |
| 4 |
Micron Technology
MU
|
$9.57M |
| 5 |
Lam Research
LRCX
|
$9M |
Top Sells
| 1 |
Apple
AAPL
|
$267M |
| 2 |
Royalty Pharma
RPRX
|
$147M |
| 3 |
Meta Platforms (Facebook)
META
|
$115M |
| 4 |
Affirm
AFRM
|
$58.3M |
| 5 |
Invesco QQQ Trust
QQQ
|
$36.3M |
Sector Composition
| 1 | Healthcare | 40.23% |
| 2 | Communication Services | 28.34% |
| 3 | Consumer Discretionary | 16.85% |
| 4 | Technology | 11.37% |
| 5 | Industrials | 2.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Light & Wonder
LNW
$7.76B
| $179M | 16.8% | 2,678,571 | – | – |
|
2
Alphabet (Google) Class A
GOOGL
$2.57T
| $177M | 16.59% | 61,016 -54 | -0.1% | -$156K |
|
|
3
Royalty Pharma
RPRX
$15.6B
| $138M | 12.96% | 3,464,990 -3,677,866 | -51% | -$147M |
|
|
4
Meta Platforms (Facebook)
META
$1.86T
| $125M | 11.75% | 372,125 -340,948 | -48% | -$115M |
|
5
AbCellera Biologics
ABCL
$1.25B
| $58.7M | 5.51% | 4,105,095 | – | – |
|
|
EQRX
6
DELISTED
EQRx, Inc. Common Stock
EQRX
| $35.9M | 3.37% | +5,262,161 | New | +$35.9M |
|
7
10x Genomics
TXG
$1.74B
| $27.7M | 2.6% | 186,143 | – | – |
|
8
Recursion Pharmaceuticals
RXRX
$2.04B
| $25.9M | 2.43% | 1,509,254 | – | – |
|
|
9
Affirm
AFRM
$28.8B
| $17.5M | 1.64% | 173,560 -580,244 | -77% | -$58.3M |
|
10
Revolution Medicines
RVMD
$7.1B
| $16.9M | 1.58% | 670,382 | – | – |
|
11
Relay Therapeutics
RLAY
$619M
| $16.6M | 1.56% | 541,124 | – | – |
|
12
Praxis Precision Medicines
PRAX
$958M
| $15.3M | 1.44% | 778,517 | – | – |
|
|
13
Grab
GRAB
$20.3B
| $14.3M | 1.34% | +2,000,000 | New | +$14.3M |
|
14
Tenaya Therapeutics
TNYA
$184M
| $12.8M | 1.2% | 673,270 | – | – |
|
15
Rocket Lab Corporation Common Stock
RKLB
$23.4B
| $12.3M | 1.15% | 1,000,000 | – | – |
|
|
MEKA
16
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
| $11.6M | 1.09% | 1,000,000 | – | – |
|
17
PureCycle Technologies
PCT
$2.57B
| $10.2M | 0.96% | 1,069,600 | – | – |
|
|
18
Confluent
CFLT
$6.85B
| $9.94M | 0.93% | +130,383 | New | +$9.94M |
|
|
19
Micron Technology
MU
$133B
| $9.57M | 0.9% | +102,684 | New | +$9.57M |
|
20
Nurix Therapeutics
NRIX
$714M
| $9.11M | 0.86% | 314,762 | – | – |
|
|
21
Lam Research
LRCX
$127B
| $9M | 0.85% | +12,521 | New | +$9M |
|
|
KNTE
22
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $8.83M | 0.83% | 498,001 | – | – |
|
23
Applied Materials
AMAT
$128B
| $7.96M | 0.75% | +50,553 | New | +$7.96M |
|
24
Advanced Micro Devices
AMD
$264B
| $7.86M | 0.74% | +54,610 | New | +$7.86M |
|
25
Intel
INTC
$107B
| $7.77M | 0.73% | +150,806 | New | +$7.77M |
|